TickerFacts.

Celldex Therapeutics, Inc. (CLDX): Revenue

Annual figures by period end, from SEC filings.

$1.54M
Year ended 2025-12-31
$158.0K
Trailing 12 months to 2026-06-30
-13.1%
3-year compound annual growth
-26.9%
5-year compound annual growth
-11.9%
10-year compound annual growth
$46.79M2009-12-31: $15.18M2010-12-31: $46.79M2011-12-31: $9.27M2012-12-31: $11.20M2013-12-31: $4.11M2014-12-31: $3.59M2015-12-31: $5.48M2016-12-31: $6.79M2017-12-31: $12.74M2018-12-31: $9.54M2019-12-31: $3.57M2020-12-31: $7.42M2021-12-31: $4.65M2022-12-31: $2.36M2023-12-31: $6.88M2024-12-31: $7.02M2025-12-31: $1.54M$1.54M
2009-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$1.54M-78.0%2026-02-25, From 2025-01-01
2024-12-31$7.02M+2.0%2026-02-25, From 2024-01-01
2023-12-31$6.88M+192.0%2026-02-25, From 2023-01-01
2022-12-31$2.36M-49.3%2025-02-27, From 2022-01-01
2021-12-31$4.65M-37.3%2024-02-26, From 2021-01-01
2020-12-31$7.42M+107.6%2023-02-28, From 2020-01-01
2019-12-31$3.57M-62.5%2022-02-28, From 2019-01-01
2018-12-31$9.54M-25.2%2021-03-29, From 2018-01-01
2017-12-31$12.74M+87.8%2020-03-26, From 2017-01-01
2016-12-31$6.79M+23.8%2019-03-07, From 2016-01-01
2015-12-31$5.48M+52.8%2018-03-07, From 2015-01-01
2014-12-31$3.59M-12.8%2017-03-14, From 2014-01-01
2013-12-31$4.11M-63.3%2016-02-25, From 2013-01-01
2012-12-31$11.20M+20.9%2015-02-24, From 2012-01-01
2011-12-31$9.27M-80.2%2014-03-03, From 2011-01-01
2010-12-31$46.79M+208.3%2013-03-08, From 2010-01-01
2009-12-31$15.18Mn/a2012-03-08, From 2009-01-01

Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Celldex Therapeutics, Inc. (CLDX)2025-12-31$1.54M-78.0%
Volitionrx Ltd (VNRX)2025-12-31$1.73M+40.0%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$4.05M+115.6%
Biomerica Inc (BMRA)2026-05-31$4.45M-16.2%
Anbio Biotechnology (NNNN)2025-12-31$8.65M+5.6%
Aspira Women's Health Inc. (AWHL)2025-12-31$9.22M+0.4%
Immucell Corp (ICCC)2025-12-31$27.64M+4.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$40.52M+7.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$67.67M+16.9%

Compare CLDX, VNRX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗